Assoc Prof Dr. Maria Teresa Arias Loste | Biomedical | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Maria Teresa Arias Loste, Biomedical, Best Researcher Award

Maria Teresa Arias Loste at Instituto de Investigación Marqués de Valdecilla, Spain

Professional Profile

🌟 Summary:

Assoc. Prof. Dr. María Teresa Arias Loste is a renowned Consultant Physician Specialist in Gastroenterology at the University Hospital Marqués de Valdecilla. With a solid academic background and extensive research experience, she has significantly contributed to the field of Gastroenterology, particularly in Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Associate Steatotic Liver Disease (MASLD).

🎓 Education:

  • Ph.D. in Biomedicine and Health Sciences, University of Cantabria, 2017
  • Master’s Degree in Hepatology, University of Alcalá and Autonomous University of Madrid, 2014
  • Bachelor of Medicine and Surgery, University of Zaragoza, 2005

💼 Professional Experience:

  • Consultant Physician Specialist in Gastroenterology, University Hospital Marqués de Valdecilla, 2012-present
  • Fellow Researcher, López Albo / Marqués de Valdecilla Research Institute Foundation, 2010-2012
  • Consultant Physician Specialist in Gastroenterology, Marqués de Valdecilla University Hospital, 2010
  • Resident Physician in Gastroenterology, University Hospital Marques de Valdecilla, 2006-2010

🔬 Research Interest:

Dr. Arias Loste’s research focuses on the immunological, genetic, and metabolic mechanisms of NAFLD and MASLD. She has been involved in numerous clinical trials and projects, including leading studies on the brain-liver axis in psychosis patients and innovative MASLD monitoring and telemedicine initiatives.

📖 Publications Top Noted:

Paper Title: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis
  • Authors: Noureddin, M., Truong, E., Mayo, R., Mato, J.M., Sanyal, A.J.
  • Journal: Hepatology
  • Year: 2024
  • Citations: 15
Paper Title: An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
  • Authors: Zhang, L., El-Shabrawi, M., Baur, L.A., George, J., Zheng, M.-H.
  • Journal: Med
  • Year: 2024
  • Citations: 1
Paper Title: Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
  • Authors: Iruzubieta, P., Santos-Laso, A., Arias-Loste, M.T., Calleja, J.L., Crespo, J.
  • Journal: Journal of Hepatology
  • Year: 2024
  • Citations: 1
Paper Title: Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
  • Authors: Puente, A., Fortea, J.I., Del Pozo, C., Bañares, R., Crespo, J.
  • Journal: Digestive and Liver Disease
  • Year: 2024
Paper Title: Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk
  • Authors: Martín-Escolano, R., Vidal-Alcántara, E.J., Crespo, J., Jiménez-Sousa, M.Á., Fernández-Rodríguez, A.
  • Journal: Immunity and Ageing
  • Year: 2023
  • Citations: 1